LIV1 has been described as an estrogen-inducible gene that is upregulated in ER + BC and is part of the PAM50 signature (membrane permeability module) dedicated to prognostication of HR+/HER2- tumors [38,39]. This evidence concerns the gene ERBB2 and breast cancer.